Prevalence of Hepatitis B and C in prisons worldwide: A meta-analysis during the years 2005-2015
Open Access
- 30 April 2018
- journal article
- review article
- Published by Biomedical Research and Therapy in Biomedical Research and Therapy
- Vol. 5 (4), 2235-2251
- https://doi.org/10.15419/bmrat.v5i4.436
Abstract
Background: Viral hepatitis is still considered as a major cause of burden of disease in the world, and is the most common cause of cirrhosis and liver cancer. Prisoners are one of the groups most at risk for hepatitis. This study aimed to investigate the prevalence of hepatitis B and C in prisons worldwide during the years 2005-2015. Method: In order to find relevant articles published from 2005 to 2015, two members of the research team searched the databases of PubMed, Scopus, and Web of Science. The study was conducted using the random effects model and the fixed effects model. In order to examine heterogeneity, Cochran Q test was used at an error level of less than 10%; its quantity was estimated using the I2 indicator. The publication bias was measured using Begg’s rank correlation test and Egger’s linear regression method. After extracting the required data, the meta-analysis was performed using the software Stata 12. Results: A total of 43 studies which met the inclusion criteria were analyzed. The results showed that the overall prevalence of hepatitis B in prisoners was 5.17% (95% CI: 2.19-9.30). The highest prevalence, that is, 13.14% (95% CI: 11.99-14.36), was observed in Africa. According to the World Health Organization (WHO) classification, the highest prevalence, that is, 5.04% (95% CI: 4.45-5.67), was observed in the Western Pacific region. The prevalence of hepatitis B in men and women were, respectively, 6.70% (95% CI: 6.52-6.88) and 4.34% (95% CI: 3.98-4.79). The results showed that the overall prevalence of hepatitis C in prisoners was 13.22% (95% CI: 8.95- 8.16). The highest prevalence, that is, 26.4% (95% CI: 25.05-27.87), was observed in Australia. According to the WHO classification, the highest prevalence of hepatitis C, that is, 24.26% (95% CI: 21.6-27.02), was observed in the Southeast Asia region. The prevalence of hepatitis B in men and women were, respectively, 9.33% (95% CI: 1.56-1.98) and 6.25% (95% CI: 5.78-6.74). Conclusion: The prevalence of hepatitis B and C in prisoners was greater than that in the general population, and the prevalence in men was greater than that in women. Appropriate and effective interventions to reduce transmission of hepatitis B and C in the prisons worldwide is essential.Keywords
This publication has 29 references indexed in Scilit:
- Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison settingBMC Public Health, 2013
- Risk Prison and Hepatitis B Virus Infection among Inmates with History of Drug Injection in Isfahan, IranThe Scientific World Journal, 2013
- Burden of Infectious Diseases, Substance Use Disorders, and Mental Illness among Ukrainian Prisoners Transitioning to the CommunityPLOS ONE, 2013
- Low incidence of hepatitis C virus among prisoners in ScotlandAddiction, 2013
- Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR IranHepatitis Monthly, 2012
- Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in PakistanInternational Journal of Infectious Diseases, 2010
- Hepatitis B and hepatitis C in Pakistan: prevalence and risk factorsInternational Journal of Infectious Diseases, 2009
- Prison health and public health responses at a regional prison in Western AustraliaAustralian and New Zealand Journal of Public Health, 2008
- Correlates of HIV, HBV, and HCV infections in a prison inmate population: Results from a multicentre study in ItalyJournal of Medical Virology, 2005
- Infection of a human hepatoma cell line by hepatitis B virusProceedings of the National Academy of Sciences of the United States of America, 2002